Update shared on 25 Oct 2025
Fair value Decreased 1.59%Blackstone's average analyst price target has been adjusted modestly lower, decreasing by approximately $3 to $178.79. Analysts cite factors such as margin pressure, shifting management fee expectations, and a mixed outlook for future results despite ongoing portfolio growth.
Analyst Commentary
Recent analyst commentary on Blackstone reveals a mixture of optimism regarding the company’s strategic position and caution over potential headwinds. The range of updated price targets and associated commentary helps illustrate these underlying views.
Bullish Takeaways- Bullish analysts are increasing price targets, citing expectations of a rebound in the capital markets. This is seen as supportive of valuation upside.
- The firm continues to attract solid fundraising, which signals ongoing investor confidence and positions Blackstone for long-term growth opportunities.
- Initiations with favorable ratings underscore a belief in Blackstone’s fundamental business strength and execution capabilities within the alternative asset management space.
- Some analysts highlight that Blackstone’s diversified platform and consistent portfolio growth remain attractive, even amid a shifting economic environment.
- Bearish analysts are cutting price targets in response to concerns over near-term margin compression and decelerating management fee growth.
- Recent quarters have elicited caution due to softer financial results, particularly with regard to fee-related earnings margins and muted realizations forecasted in upcoming periods.
- There is apprehension around low investing activity and mixed asset returns, which could weigh on Blackstone’s performance over the short term.
- Downward movement in stock price following earnings, despite seemingly solid results, has been linked to tempered expectations for future quarters.
What's in the News
- Blackstone and TPG are in advanced discussions to acquire medical device maker Hologic, with a potential deal value exceeding $17 billion. Negotiations are ongoing and no final agreement has been reached (Bloomberg).
- Blackstone is set to invest $706 million to become the largest shareholder in India's Federal Bank, acquiring a 9.99% stake (Bloomberg).
- SL Green Realty has agreed to purchase a Midtown Manhattan office building from Blackstone for $730 million, highlighting continued optimism in the New York City office market (Wall Street Journal).
- Blackstone is exploring a bid for Big Yellow Group, the UK self-storage operator. This is at a preliminary stage with no bid submitted yet (Bloomberg).
- Blackstone is among the suitors considering offers for Optum's UK health services unit, alongside other private equity interests (Sky News).
Valuation Changes
- Consensus Analyst Price Target: Decreased modestly from $181.68 to $178.79, reflecting a slightly tempered outlook.
- Discount Rate: Edged down marginally from 8.20% to 8.19%.
- Revenue Growth: Increased from 16.73% to 19.70%, which indicates improved growth projections.
- Net Profit Margin: Declined slightly from 48.85% to 48.30%.
- Future P/E: Dropped significantly from 28.56x to 17.69x. This suggests a lower forward valuation multiple.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.
